Kneu Health

- 14/10/2025
- Seed
- $5,600,000
Backed by over a decade of Oxford research, Kneu transforms smartphones into clinical-grade monitors for neurological conditions, starting with Parkinson’s and dementia. By capturing subtle changes in movement, cognition, and wellbeing, our technology provides objective insights that go beyond self-reporting. This empowers people living with neurological conditions, supports clinicians in delivering more personalized care, and helps health systems in the UK and US reduce pressures while improving outcomes.
- Industry Hospital & Health Care
- Website https://kneuhealth.com/
- LinkedIn https://www.linkedin.com/company/kneu-health-ltd/
Related People
Caroline CakeFounder

I'm CEO of Kneu Health, a University of Oxford spinout on a mission to transform care for people with Parkinson’s and dementia. We’ve recently achieved a major milestone — FDA 510(k) clearance for our smartphone-based digital platform — bringing us one step closer to making neurological care radically more accessible and scalable.
I have a proven track record in building and leading high-impact healthtech businesses, securing multi-million-pound investments, navigating complex regulatory pathways, and delivering commercial growth in mission-driven environments.
Previously, I was Entrepreneur in Residence at Oxford Science Enterprises and CEO of Health Data Research UK (HDRUK), the UK’s national institute for health data science, where I led national strategy and cross-sector innovation to harness data for patient benefit.
Before that, I was a Director at 2020 Delivery (now The PSC), advising NHS trusts, universities, and central government on strategy, transformation, and delivery. I began my career as a Chartered Engineer at ICI, followed by roles at McKinsey & Company.
I hold an MBA from Harvard Business School and MA/MEng from the University of Cambridge. I’m passionate about scaling data-led innovation, building exceptional teams, and improving lives through technology.